SpeakEasy Cannabis Club Ltd. announced the addition of Frey Garabagi as its newly appointed Chief Scientific Officer and to the company's Board of Directors. Mr. Garabagi's distinguished career includes a degree in the field of plant molecular genetics and biotechnology, with 10 years of post-doctoral research experience from the University of Guelph. Frey held the position of Vice President of Research and Quality Affairs at Emerald Health Therapeutics Inc. as a research scientist, and inventor from September 2015 to January 2019. Mr. Garabagi currently holds full security clearance and is actively involved in various cannabis related projects such as breeding, strain characterization, product development, extraction technologies and development of cannabis oil formulations, preclinical pharmacokinetic studies, and cannabis genetics. In 2012, Frey founded Herbaceous Inc., a company that organized preclinical research with non- psychoactive cannabinoids on epilepsy and obesity. The Company received its right-to-build letter from Health Canada in February 2014, and secured $6 M investment capital for building its facility in 2015.